A large body of literature documents the occurrence of alterations in the physiology of both
central and peripheral modulators of appetite in acute patients with anorexia nervosa (AN) …

A breakthrough using “reverse pharmacology” identified and characterized acyl ghrelin from
the stomach as the endogenous cognate ligand for the growth hormone (GH) secretagogue …

This study examined the clinical significance of the loss of control over eating as a key
component of eating disorders. It investigated the association of eating-related …

Objective: This paper considers whether the criteria currently used to classify the diagnosis
of binge eating disorder (BED) are valid and appropriate. Method: We review evidence that …

Ghrelin is a 28-amino-acid peptide hormone, first described in 1999 and broadly expressed
in the organism. As the only known orexigenic hormone secreted in the periphery, it …

Eating Disorders presents a comprehensive and accessible investigation of eating
disorders, spanning topics such as historical and cross-cultural trends in prevalence of …

This chapter focuses on the neurobiology of anorexia nervosa (AN) and bulimia nervosa
(BN). AN and BN are disorders characterized by aberrant patterns of feeding behavior and …

The equilibrium and reciprocal actions among appetite-stimulating (orexigenic) and appetite-
suppressing (anorexigenic) signals synthesized in the gut, brain, microbiome and adipose …

Objectives: To review the main phenomenological variants observed among bulimia
spectrum syndromes and the factors believed to act etiologically for them and also to …

Introduction The nutritional status of patients in the intensive care unit (ICU) appears to
decline not only during their stay in the ICU but also after discharge from the ICU. Recent …